South Korea Approves country's First Domestically Produced COVID-19 Vaccine 'SKYcovione'

South Korea has approved the country's first domestically developed COVID-19 vaccine for administering, on June 29. The country's health ministry said that the domestically produced SKYcovione vaccine builds more immunity than the broadly used AtraZeneca vaccine. The SKYcovione is a two-shot vaccine, which is produced by SK Bioscience, and can now be administered for adults above 18 years of age.